19-51341834-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001163922.3(VSIG10L):āc.214T>Cā(p.Ser72Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000058 in 1,551,638 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001163922.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VSIG10L | NM_001163922.3 | c.214T>C | p.Ser72Pro | missense_variant | 2/10 | ENST00000335624.5 | NP_001157394.1 | |
VSIG10L-AS1 | NR_186316.1 | n.808-16A>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VSIG10L | ENST00000335624.5 | c.214T>C | p.Ser72Pro | missense_variant | 2/10 | 5 | NM_001163922.3 | ENSP00000335623.3 | ||
VSIG10L-AS1 | ENST00000594311.1 | n.133-38A>G | intron_variant | 5 | ||||||
VSIG10L-AS1 | ENST00000601148.5 | n.133-16A>G | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152150Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000572 AC: 8AN: 1399370Hom.: 0 Cov.: 77 AF XY: 0.00000580 AC XY: 4AN XY: 690200
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152268Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74454
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 19, 2024 | The c.214T>C (p.S72P) alteration is located in exon 2 (coding exon 2) of the VSIG10L gene. This alteration results from a T to C substitution at nucleotide position 214, causing the serine (S) at amino acid position 72 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at